Drug Shortage Report for MYLAN-BUPROPION XL
Report ID | 110465 |
Drug Identification Number | 02382083 |
Brand name | MYLAN-BUPROPION XL |
Common or Proper name | BUPROPION |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 90BT, 500BT |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-30 |
Estimated end date | 2020-06-30 |
Actual end date | 2020-06-30 |
Shortage status | Resolved |
Updated date | 2020-07-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-04-02 | English | Compare |